Sort
53,477 grants matching “addiction”
A Multi-Method Study of Extreme Alcohol Drinkers in the Lab and in Real-Life: Increasing Precision of Assessments of Extreme Drinking Determinants
$474,514Timothy J Trull · University Of Missouri-Columbia · R01 · FY2022 · AA
Elucidating the 3-D epigenetic determinants of activity-dependent gene expression in mammalian neurons
$474,500Jennifer Elizabeth Phillips-Cremins · University Of Pennsylvania · R01 · FY2020 · NS
Integrative Genetics and Genomics
$474,490Vivek Philip · Jackson Laboratory · P50 · FY2020 · DA
HEAL initiative: Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial: Cincinnati site
$474,473Stephanie L Merhar · Cincinnati Childrens Hosp Med Ctr · UG1 · FY2021 · HD
Development of Potential Treatment Medications for Drug Abuse
$474,469Bruce E Blough · Research Triangle Institute · R01 · FY2010 · DA
Developing Active Stimulation and Monitoring Technologies to Optimize Pain and Nociception Management During Regional Anesthesia, General Anesthesia, and Post-Operative Care
$474,416Tuan Le Mau · Pascall Systems, Incorporated · R42 · FY2023 · NS
Longitudinal Pathways to the Use of Health Services
$474,383Judith S Brook · New York University School Of Medicine · R01 · FY2015 · DA
N-Acetyl Cysteine plus Behavioral Therapy for Nicotine Dependent Pathological Gam
$474,322Jon E Grant · University Of Minnesota · RC1 · FY2010 · DA
Interpreting the regulatory mechanisms underlying the predisposition to substance use disorders
$474,300Andreas Robert Pfenning · Carnegie-Mellon University · DP1 · FY2018 · DA
Interpreting the regulatory mechanisms underlying the predisposition to substance use disorders
$474,300Andreas Robert Pfenning · Carnegie-Mellon University · DP1 · FY2019 · DA
Interpreting the regulatory mechanisms underlying the predisposition to substance use disorders
$474,300Andreas Robert Pfenning · Carnegie-Mellon University · DP1 · FY2020 · DA
Interpreting the regulatory mechanisms underlying the predisposition to substance use disorders
$474,300Andreas Robert Pfenning · Carnegie-Mellon University · DP1 · FY2021 · DA
Interpreting the regulatory mechanisms underlying the predisposition to substance use disorders
$474,300Andreas Robert Pfenning · Carnegie-Mellon University · DP1 · FY2022 · DA
Hippocampal interactions with striatal subnetworks for reward prediction and evaluation
$474,114Lucas L Sjulson · Albert Einstein College Of Medicine · R01 · FY2023 · DA
SELECTIVE NONPEPTIDE OPIOID LIGANDS
$474,088University Of Minnesota Twin Cities · R37 · FY2002 · DA
Behavioral Treatment of Adolescent Marijuana Use
$474,056Alan Jeffrey Budney · Univ Of Arkansas For Med Scis · R01 · FY2008 · DA
Stress Response and Smoking Cessation in Depressed Youth
$474,053Uma Rao · Ut Southwestern Medical Center · R01 · FY2007 · DA
Optimizing the use of ketamine to reduce chronic postsurgical pain
$474,022Jing Wang · New York University School Of Medicine · UH3 · FY2024 · CA
Building Bridges to Allow Cross-species Translational genetics for the Study of Addiction
$474,000Sandra Sanchez Roige · University Of California, San Diego · DP1 · FY2023 · DA
Building Bridges to Allow Cross-species Translational genetics for the Study of Addiction
$474,000Sandra Sanchez Roige · University Of California, San Diego · DP1 · FY2021 · DA
Building Bridges to Allow Cross-species Translational genetics for the Study of Addiction
$474,000Sandra Sanchez Roige · University Of California, San Diego · DP1 · FY2025 · DA
Building Bridges to Allow Cross-species Translational genetics for the Study of Addiction
$474,000Sandra Sanchez Roige · University Of California, San Diego · DP1 · FY2022 · DA
Building Bridges to Allow Cross-species Translational genetics for the Study of Addiction
$474,000Sandra Sanchez Roige · University Of California, San Diego · DP1 · FY2024 · DA
Making and breaking opioid memories to prevent relapse
$474,000Erin Calipari · Vanderbilt University · DP1 · FY2019 · DA
Making and breaking opioid memories to prevent relapse
$474,000Erin Calipari · Vanderbilt University · DP1 · FY2020 · DA